Peripheral Nerve Stimulation Registry for Intractable Migraine Headache

Peripheral Nerve Stimulation Registry for Intractable Migraine Headache

The purpose of this study is to evaluate the long-term safety and performance of neurostimulation for the treatment of intractable chronic migraine as well as to detect infrequent complications or problems only apparent in "real-world" practice

• Patient is 18 years of age or older.

• Patient has signed and received a copy of the Informed Consent form;

• Patient has been implanted with a St. Jude Medical CE approved implantable neurostimulation system for the treatment of intractable chronic migraine:

  • Patient diagnosed with chronic migraine (15 or more days per month with headache lasting at least 4 hours per day)
  • Patient has failed three or more preventative drugs for treatment of their migraine
  • Patient has at least moderate disability determined using a validated migraine disability instrument [e.g., MIDAS >11 or HIT-6 >56]

Exclusion Criteria:

• NA